Publications by authors named "Gary Tong"

Claim this Profile
M
Multi-modal analyses of proteomic measurements associated with type 2 diabetes from the Project Baseline Health Study.
Alessandra Breschi, Yuliang Wang, Sarah Short, Wilman Luk, David Erani, Gary J Tong

Commun Med (Lond)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early immune factors associated with the development of post-acute sequelae of SARS-CoV-2 infection in hospitalized and non-hospitalized individuals.
Jacqueline M Leung, Michelle J Wu, Pouya Kheradpour, Chen Chen, Katherine A Drake, Gary Tong

Front Immunol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-omic profiling reveals early immunological indicators for identifying COVID-19 Progressors.
Katherine A Drake, Dimitri Talantov, Gary J Tong, Jack T Lin, Simon Verheijden

Clin Immunol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-omic Profiling Reveals Early Immunological Indicators for Identifying COVID-19 Progressors.
Katherine A Drake, Dimitri Talantov, Gary J Tong, Jack T Lin, Simon Verheijden

bioRxiv· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychometric testing of the Fall Risks for Older People in the Community screening tool (FROP-Com screen) for community-dwelling people with stroke.
Shamay S M Ng, Tai-Wa Liu, Patrick W H Kwong, Ho-Man Choy, Terence Y K Fong, Gary Y H Tong

PLoS One· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Combinations for Alzheimer's Disease: Current and Future Pharmacotherapy Options.
Jeffrey L Cummings, Gary Tong, Clive Ballard

J Alzheimers Dis· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Present Algorithms and Future Treatments for Alzheimer's Disease.
George T Grossberg, Gary Tong, Anna D Burke, Pierre N Tariot

J Alzheimers Dis· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current state of Alzheimer's fluid biomarkers.
José Luis Molinuevo, Scott Ayton, Richard Batrla, Martin M Bednar, Tobias Bittner, Gary Tong

Acta Neuropathol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable.
David S Knopman, Samantha Budd Haeberlein, Maria C Carrillo, James A Hendrix, Geoff Kerchner, Gary Tong

Alzheimers Dement· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Cas9-based toolkit to program gene expression in Saccharomyces cerevisiae.
Amanda Reider Apel, Leo d'Espaux, Maren Wehrs, Daniel Sachs, Rachel A Li, Gary J Tong

Nucleic Acids Res· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An integrated multi-study analysis of intra-subject variability in cerebrospinal fluid amyloid-β concentrations collected by lumbar puncture and indwelling lumbar catheter.
Brendan P Lucey, Celedon Gonzales, Ujjwas Das, Jinhe Li, Eric R Siemers, Gary Tong

Alzheimers Res Ther· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease.
Hiroto Takahashi, Peng Xia, Jiankun Cui, Maria Talantova, Karthik Bodhinathan, Gary Tong

Sci Rep· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease.
Hiroto Takahashi, Peng Xia, Jiankun Cui, Maria Talantova, Karthik Bodhinathan, Gary Tong

Sci Rep· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss.
Maria Talantova, Sara Sanz-Blasco, Xiaofei Zhang, Peng Xia, Mohd Waseem Akhtar, Gary Tong

Proc Natl Acad Sci U S A· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development.
Adam L Boxer, Michael Gold, Edward Huey, Fen-Biao Gao, Edward A Burton, Gary Tong

Alzheimers Dement· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier).
Adam L Boxer, Michael Gold, Edward Huey, William T Hu, Howard Rosen, Gary Tong

Alzheimers Dement· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamics of selective inhibition of γ-secretase by avagacestat.
Charles F Albright, Randy C Dockens, Jere E Meredith, Richard E Olson, Randy Slemmon, Gary Tong

J Pharmacol Exp Ther· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A contrast in safety, pharmacokinetics and pharmacodynamics across age groups after a single 50 mg oral dose of the γ-secretase inhibitor avagacestat.
Gary Tong, Jun-Sheng Wang, Oleksandr Sverdlov, Shu-Pang Huang, Randy Slemmon

Br J Clin Pharmacol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET Imaging and biodistribution of chemically modified bacteriophage MS2.
Michelle E Farkas, Ioana L Aanei, Christopher R Behrens, Gary J Tong, Stephanie T Murphy

Mol Pharm· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of (5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate (BMS-927711): an oral calcitonin gene-related peptide (CGRP) antagonist in clinical trials for treating migraine.
Guanglin Luo, Ling Chen, Charles M Conway, Rex Denton, Deborah Keavy, Gary Tong

J Med Chem· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of single doses of avagacestat (BMS-708163) on cerebrospinal fluid Aβ levels in healthy young men.
Gary Tong, Lorna Castaneda, Jun-Sheng Wang, Oleksandr Sverdlov, Shu-Pang Huang

Clin Drug Investig· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A placebo-controlled, multiple ascending dose study to evaluate the safety, pharmacokinetics and pharmacodynamics of avagacestat (BMS-708163) in healthy young and elderly subjects.
Randy Dockens, Jun-Sheng Wang, Lorna Castaneda, Oleksandr Sverdlov, Shu-Pang Huang, Gary Tong

Clin Pharmacokinet· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter, randomized, double-blind, placebo-controlled, single-ascending dose study of the oral γ-secretase inhibitor BMS-708163 (Avagacestat): tolerability profile, pharmacokinetic parameters, and pharmacodynamic markers.
Gary Tong, Jun-Sheng Wang, Oleksandr Sverdlov, Shu-Pang Huang, Randy Slemmon

Clin Ther· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual-surface modified virus capsids for targeted delivery of photodynamic agents to cancer cells.
Nicholas Stephanopoulos, Gary J Tong, Sonny C Hsiao, Matthew B Francis

ACS Nano· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excitatory glycine responses of CNS myelin mediated by NR1/NR3 "NMDA" receptor subunits.
Juan C Piña-Crespo, Maria Talantova, Ileana Micu, Bradley States, H-S Vincent Chen, Gary Tong

J Neurosci· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis